亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

Weaponizing Immune Cells with New Liposomes to Target Metastatic Cancer

詳細技術說明
Thisinvention describes a method to functionalized cells using liposomenanoparticles for inhibiting metastatic cancer cells.
*Abstract

Circulating blood cells are functionalized directly in vivo, which then adhere to circulating tumor, immune, or other cells for the treatment of metastasis, inflammation, and other conditions.

 

In one embodiment, Cornell researchers have used this approach to capture and kill circulating tumor cells (CTC) in blood and lymphatic vessels. Leukocytes were functionalized with TRAIL-decorated liposome nanoparticles. These leukocytes, bound to CTC, then induce apoptosis, thereby eliminating CTC from circulation.

Since greater than 90% of cancer related deaths are caused by metastasis, this technology offers a potentially important treatment in an area of significant and unmet need.

Additional potential applications for this approach include use of other decorated nanoparticles for various types of cancer treatment, as well as for anti-inflammatory conditions. A further utilization of this technology involves its use in imaging techniques.

 

Potential Commercial Applications:

  • Treatment for highly metastatic cancers such as breast, prostate, and lung cancer
  • Treatment for inflammation

 

Advantages

Representsa major breakthrough in cancer treatment, as there are no existing technologiesthat can both capture and kill CTC in vivo.

*Licensing
Jeff Fearnjcf55@cornell.edu607-254-4502
其他

 

國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備